Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
KEYS to SUCCESS in small start-ups vs. big pharma
Summary
In this episode, Tom Caravela is joined by Jim Morgan to explore the unique landscape of working in small pharma companies. Jim shares insights from his extensive background in large pharma, highlighting the pros and challenges of transitioning to smaller firms. They discuss the critical role of field medical in companies lacking commercial teams and the recruitment challenges faced by small pharma. The conversation delves into strategic and tactical roles, team dynamics, and career progression within small biotech environments. Jim offers valuable advice for those considering a move to small pharma startups, emphasizing job stability and growth opportunities.
Jim Morgan, National Director, Oncology MSLs, discusses the KEY to success for working in small start ups vs. big pharma.
Jim shares…
👉 Pros and cons for Small vs. Large Pharma
👉 How to overcome lack of infrastructure and support
👉 What its like to navigate in an early stage, pre-commercial environment
👉 How to be both strategic and tactical at the same time
👉 What skills are mandatory for Small Pharma vs Large
Small Pharma Companies, Transitioning to Smaller Firms, Field Medical Roles, Recruitment Challenges, Career Progression in Biotech
Related Topics
You May Also Like
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis